181 related articles for article (PubMed ID: 26866009)
21. Relationship between HLA tissue type, CMV infection, and acute graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: single-center experience.
Kekik C; Besisik SK; Seyhun Y; Oguz FS; Sargin D; Carin MN
Transplant Proc; 2009 Nov; 41(9):3859-62. PubMed ID: 19917401
[TBL] [Abstract][Full Text] [Related]
22. KIR and Human Leukocyte Antigen Genotype Associated Risk of Cytomegalovirus Disease in Renal Transplant Patients.
Michelo CM; van der Meer A; Tijssen HJ; Zomer R; Stelma F; Hilbrands LB; Joosten I
Transplantation; 2015 Jul; 99(7):1506-13. PubMed ID: 25427165
[TBL] [Abstract][Full Text] [Related]
23. The influence of HLA A, B, C, DR alleles and HLA haplotypes on cytomegalovirus-specific cell mediated immunity in seropositive Korean kidney transplant candidates.
Lee H; Kang H; Yun S; Ryu JH; Bae H; Chung BH; Yang CW; Oh EJ
HLA; 2023 Nov; 102(5):590-598. PubMed ID: 37158113
[TBL] [Abstract][Full Text] [Related]
24. [Expression and significance of neutrophil surface adhesion molecules in renal transplant recipients with cytomegalovirus infection].
Xiao L; Bai J; He XY; Han Y; Xu XG; Fan WM; Bi LL; Gao Y; Kong XR; Wei YX; Shi BY
Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1562-5. PubMed ID: 27266682
[TBL] [Abstract][Full Text] [Related]
25. Effect of cytomegalovirus infection status on first-year mortality rates among orthotopic liver transplant recipients. The Boston Center for Liver Transplantation CMVIG Study Group.
Falagas ME; Snydman DR; Griffith J; Ruthazer R; Werner BG
Ann Intern Med; 1997 Feb; 126(4):275-9. PubMed ID: 9036799
[TBL] [Abstract][Full Text] [Related]
26. The influence of HLA A-B-DR matching on cytomegalovirus disease after renal transplantation. Evidence that HLA-DR7-matched recipients are more susceptible to cytomegalovirus disease.
Blancho G; Josien R; Douillard D; Bignon JD; Cesbron A; Soulillou JP
Transplantation; 1992 Nov; 54(5):871-4. PubMed ID: 1332224
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for cytomegalovirus infection and disease in renal transplant recipients: HLA-DR7 and triple therapy.
Kraat YJ; Christiaans MH; Nieman FH; van den Berg-Loonen PM; van Hooff JP; Bruggeman CA
Transpl Int; 1994 Aug; 7(5):362-7. PubMed ID: 7993574
[TBL] [Abstract][Full Text] [Related]
28. Is antibody-mediated rejection in kidney transplant recipients a risk factor for developing cytomegalovirus or BK virus infection? Results from a case-control study.
Los-Arcos I; Len O; Perello M; Torres IB; Codina G; Esperalba J; Sellarés J; Moreso F; Seron D; Gavaldà J
J Clin Virol; 2019 Jan; 110():45-50. PubMed ID: 30537648
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.
Deborska-Materkowska D; Perkowska-Ptasinska A; Sadowska A; Gozdowska J; Ciszek M; Serwanska-Swietek M; Domagala P; Miszewska-Szyszkowska D; Sitarek E; Jozwik A; Kwiatkowski A; Durlik M
BMC Infect Dis; 2018 Apr; 18(1):179. PubMed ID: 29661141
[TBL] [Abstract][Full Text] [Related]
30. Impact of Cytomegalovirus Serostatus on Allograft Loss and Mortality Within the First Year After Kidney Transplantation: An Analysis of the National Transplant Registry.
Bruminhent J; Dajsakdipon T; Ingsathit A; Supaporn T; Prommool S; Watcharananan SP
Transplant Proc; 2020 Apr; 52(3):829-835. PubMed ID: 32113693
[TBL] [Abstract][Full Text] [Related]
31. Susceptibility of HLA-E*01:03 Allele Carriers to Develop Cytomegalovirus Replication After Living-Donor Kidney Transplantation.
Guberina H; da Silva Nardi F; Michita RT; Dolff S; Bienholz A; Heinemann FM; Wilde B; Trilling M; Horn PA; Kribben A; Witzke O; Rebmann V
J Infect Dis; 2018 May; 217(12):1918-1922. PubMed ID: 29228302
[TBL] [Abstract][Full Text] [Related]
32. [Research of mHLA-G and the receptor expression with kidney rejection and CMV active infection following kidney transplantation].
Bi LL; Gao Y; Sun YJ; Kong XR; He XY; Ma XH; Zhang WH; Xiao L; Shi BY
Zhonghua Yi Xue Za Zhi; 2017 Jan; 97(2):104-107. PubMed ID: 28088953
[No Abstract] [Full Text] [Related]
33. The Donor Major Histocompatibility Complex Class I Chain-Related Molecule A Allele rs2596538 G Predicts Cytomegalovirus Viremia in Kidney Transplant Recipients.
Rohn H; Tomoya Michita R; Schwich E; Dolff S; Gäckler A; Trilling M; Le-Trilling VTK; Wilde B; Korth J; Heinemann FM; Horn PA; Kribben A; Witzke O; Rebmann V
Front Immunol; 2018; 9():917. PubMed ID: 29867932
[TBL] [Abstract][Full Text] [Related]
34. [Cytomegalovirus active infection after kidney transplantation affecting the expression of activation receptor CD226 on NKT cell].
Yu T; Liu ZJ; Xiao L; Chen W; Yao C; Kong XR; Zhou L; Xu XD; Shi BY
Zhonghua Yi Xue Za Zhi; 2019 Mar; 99(12):884-888. PubMed ID: 30917435
[No Abstract] [Full Text] [Related]
35. The relationship between COVID-19 and HLA in kidney transplant recipients, an evaluation of predictive and prognostic factors.
Ertosun MG; Özkan Ö; Darbaş Ş; Özel D; Bilge U; Sayin Ekinci N; Yilmaz VT; Uçar F; Koçak H; Özkan Ö
Clin Transplant; 2022 Feb; 36(2):e14525. PubMed ID: 34726292
[TBL] [Abstract][Full Text] [Related]
36. Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients.
Noble S; Faulds D
Drugs; 1998 Jul; 56(1):115-46. PubMed ID: 9664203
[TBL] [Abstract][Full Text] [Related]
37. Cytomegalovirus disease recurrence after ganciclovir treatment in kidney and kidney-pancreas transplant recipients.
Humar A; Uknis M; Carlone-Jambor C; Gruessner RW; Dunn DL; Matas A
Transplantation; 1999 Jan; 67(1):94-7. PubMed ID: 9921803
[TBL] [Abstract][Full Text] [Related]
38. Incidence and risk factors associated with cytomegalovirus infection after the treatment of acute rejection during the first year in kidney transplant recipients receiving preemptive therapy.
Felipe C; Ferreira AN; de Paula M; Viana L; Cristelli M; Medina Pestana J; Tedesco-Silva H
Transpl Infect Dis; 2019 Dec; 21(6):e13106. PubMed ID: 31081566
[TBL] [Abstract][Full Text] [Related]
39. Impact of donor and recipient cytomegalovirus serology on long-term survival of lung transplant recipients.
Mabilangan C; Preiksaitis J; Cervera C;
Transpl Infect Dis; 2018 Oct; 20(5):e12964. PubMed ID: 29981174
[TBL] [Abstract][Full Text] [Related]
40. The influence of mTOR inhibitors on the incidence of CMV infection in high-risk donor positive-recipient negative (D+/R-) kidney transplant recipients.
Cristelli MP; Esmeraldo RM; Pinto CM; Sandes-Freitas TV; Felipe C; Lobo CF; Viana L; Mansur J; Stopa S; Santos DWC; Grenzi PC; Aguiar WF; Tedesco-Silva H; Pestana JOM
Transpl Infect Dis; 2018 Aug; 20(4):e12907. PubMed ID: 29679515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
